2d illustrations and photos
Shares of newly public Metsera (NASDAQ:MTSR), which is developing ultra-long-acting obesity drugs, rallied 54% following a $275M initial public offering.
Metsera (NASDAQ:MTSR) shares opened at $25.50 after being priced at $18 per share, later hitting a high of $28.87. The stock recently sold for $27.75